Synapse Open Synapse
Biology

Roche breast cancer pill cleared by FDA

BioPharma Dive · · 2 min read

Wilserdly’s U.S. approval is seen by analysts as a “key first step” in an important launch for Roche, which has claimed the drug could become its top-selling product.

Latest from BioPharma Dive